missing translation for 'onlineSavingsMsg'
Learn More

SCN5A Monoclonal Antibody (4G8), Invitrogen™

Mouse Monoclonal Antibody

Brand:  Invitrogen MA127429

Product Code. 11519602

  • £466.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

MA1-27429 detects Nav 1.5 from human samples. MA1-27429 may be successfully used in immunocytochemistry, immunofluorescence and Western blot applications. The MA1-27429 immunogen is a synthetic peptide corresponding to an extracellular domain of Nav1.5.

Scn5a is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. Scn5a is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in Scn5a are a cause of long QT syndrome type 3 (LQT3), an autosomal domit cardiac disease. Alternative splicing results in several transcript variants encoding different isoforms of Scn5a. Voltage-gated sodium channesl (VGSCs) mediate regenerative cell membrane depolarization and conduction of electrical signalling in nerves and muscles. Expression of Scn5a is also detected in lymphocytes, glia, and fibroblasts. Further, Scn5a mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, Scn5a forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. Functionally, Scn5a is responsible for the initial upstroke of the action potential and the channel inactivation is regulated by intracellular calcium levels. Voltage-gated sodium channels (NaV) are responsible for action potential initiation and propagation in excitable cells, including nerve, muscle, and neuroendocrine cell types. Scn5a are also expressed at low levels in non-excitable cells, where their physiological role is unclear. Diseases associated with SCN5A include Long Qt Syndrome-3 and Brugada Syndrome 1.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SCN5A
Monoclonal
0.9 mg/mL
SCN5A
SCN5A
Synthetic peptide corresponding to a portion of the extracellular domain of Nav1.5.
100 μg
Primary
Human
Antibody
IgM
Immunocytochemistry, Immunofluorescence, Western Blot
4G8
Unconjugated
Q14524
Mouse
Affinity chromatography
RUO
6331
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.